Sign In
Buy ACTG
$4.64
-0.0900 (-1.90%)
At Close: Jun 03, 2026
Acacia Research Reports Purchase Of Portfolio Of Lice Science Assets For £223.9M
11:01am, Friday, 05'th Jun 2020Acacia Agrees to Acquire Portfolio of Life Science Assets for £223.9 million
11:00am, Friday, 05'th Jun 2020
Acacia Research Corporation ("we", "Acacia" or "the Company") (Nasdaq: ACTG), a publicly-traded investor in absolute return assets, today announced that it had entered into an agreement with Link Fund
Investors pour £4bn into funds after record outflows due to Covid-19 pandemic
10:49am, Friday, 05'th Jun 2020
The return of investment during April has been welcomed by the industry
Acacia Research Enhances Senior Management Team, Names Richard Rosenstein as CFO, Meredith Simmons as General Counsel
10:00am, Friday, 05'th Jun 2020
Acacia Research Corporation ("we," "Acacia" or "the Company") (Nasdaq: ACTG) today announced that it has enhanced and expanded its senior management team with two key appointments. Richard Rosenstein
Acacia snaps up Woodford biotech stakes in £224m deal - CityAM
08:26am, Friday, 05'th Jun 2020
US-listed patent licensing firm Acacia Research today secured a deal to buy a portfolio of biotech stakes from Neil Woodford’s failed fund for up to £223.9m.
CORRECTED-Link sells former Woodford fund's healthcare assets to Acacia for 224 mln stg
07:51am, Friday, 05'th Jun 2020Acacia Research Enhances Senior Management Team, Names Richard Rosenstein as CFO, Meredith Simmons as General Counsel
12:00am, Friday, 05'th Jun 2020
Acacia Research Corporation (“we,”
